Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen

scientific article published on May 1981

Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(19810515)47:10<2414::AID-CNCR2820471016>3.0.CO;2-W
P698PubMed publication ID6974039

P2093author name stringMiller D
Canellos GP
Weichselbaum R
Kirkwood JM
Pitman SW
Ervin TJ
P2860cites workThe variability of individual tolerance to methotrexate in cancer patientsQ33462590
Methotrexate and radiation therapy in the treatment of advanced head and neck tumorsQ46830339
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectmethotrexateQ422232
head and neck squamous cell carcinomaQ18348812
P1104number of pages8
P304page(s)2414-2421
P577publication date1981-05-01
P1433published inCancerQ326041
P1476titleIncreased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen
P478volume47